Methylprednisolone in advanced chronic lymphocytic leukaemia: rationale for, and effectiveness of treatment suggested by DiSC assay

Acta Haematologica
A G BosanquetDaniel Catovsky

Abstract

The effect of methylprednisolone on fresh cells from patients with chronic lymphocytic leukaemia (CLL) has been studied using the differential staining cytotoxicity (DiSC) assay resulting in LC90s of < or = 0.2 to 2,000 micrograms/ml. Cells from previously treated patients were, on average, significantly more sensitive to methylprednisolone than those from untreated patients (mean LC90 = 5.7 micrograms/ml, n = 61 vs 31.0 micrograms/ml, n = 17, respectively; p < 0.05). Twelve patients with advanced disease were given high-dose methylprednisolone (1 g/m2/day i.v. x 5 days). In 7 cases, > or = 3 courses were given; 3 patients did not respond (2 achieved palliation) and 4 (57%) achieved a good partial response. These latter 4 patients were all clinically resistant to chlorambucil and anthracyclines and 2 were resistant to fludarabine. In 5 cases, 1 or 2 courses were given but no patients responded. The 8 nonresponders survived a median of 3.5 months whilst the responders have survived a median of 28.5+ months (3 of 4 still alive). This work suggests a rationale for why CLL patients resistant to standard chemotherapy may benefit from high-dose methylprednisolone therapy. Due to cost and toxicity associated with therapy, the decision...Continue Reading

Citations

Aug 31, 2002·Hematological Oncology·Gerassimos A PangalisMaria K Angelopoulou
Sep 18, 2012·Journal of Hematology & Oncology·Kang Lu, Xin Wang
Jun 1, 1999·Leukemia & Lymphoma·P D ThorntonD Catovsky
May 24, 2012·Expert Opinion on Investigational Drugs·Lukáš Smolej
Jul 16, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Wei XuJian-Yong Li
Nov 6, 2002·Journal of Experimental Therapeutics & Oncology·Andrew G BosanquetPhilip B Bell
Jun 17, 2005·Expert Opinion on Pharmacotherapy·Kim M GoorMichel van Agthoven
Dec 7, 2011·Cancer Control : Journal of the Moffitt Cancer Center·Marays Veliz, Javier Pinilla-Ibarz
Sep 12, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maria Joao BaptistaFrancesc Bosch

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.